By promoting the regulation effect of miR-21 on the TGF-β1/Smad7 signaling pathway, chlorogenic acid can inhibit the level of CTGF and fibrosis markers in the treatment of liver fibrosis [153]. This evidence concerns the gene CCN2 and Hepatic fibrosis.